SUSTAINED-RELEASE NIACIN OTC USE POSES "POTENTIALLY SERIOUS" PUBLIC HEALTH PROBLEM
This article was originally published in The Tan Sheet
Executive Summary
SUSTAINED-RELEASE NIACIN OTC USE POSES "POTENTIALLY SERIOUS" PUBLIC HEALTH PROBLEM due to liver side effects, researchers concluded from a study published in the March 2 issue of the Journal of the American Medical Association. In a randomized, double-blind parallel comparison of immediate-release and sustained-release niacin, James McKenney, PharmD, Virginia Commonwealth University, et al., found that more than half of the patients receiving a sustained-release form of niacin developed hepatotoxic reactions.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning